Clinical Trial Results:
A Phase II Study of Intravenous (IV) Vinflunine in Patients with Locally Advanced or Metastatic Transitional Cell Carcinoma (TCC) of the Urothelium
Revised Protocol #01, version 2.0 incorporating Protocol Amendment #04, and
Pharmacogenetics Blood Sample Amendment #01, dated 18-Oct-04
Primary Tumor Tissue Sample Amendment #02, dated 18-Oct-04
Pharmacokinetics Blood Sample Amendment #03, dated 18-Oct-04
Summary
|
|
EudraCT number |
2005-001463-64 |
Trial protocol |
AT ES SE IT |
Global completion date |
10 Apr 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Dec 2016
|
First version publication date |
07 Dec 2016
|
Other versions |
|
Summary report(s) |
CA183-001_Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.